MPEL Volume Alert - MPEL 25.25 Melco Crown Entertainment

New Post Public Reply Private Reply Replies (0) Message Board
leahanne
MPEL Volume Alert - MPEL 25.25 Melco Crown Entertainment Limited $MPEL Hit a high of 25.55 Currently 11:15 Last price 25.25 +0.48 +1.94% With a day low of 24.90 and a current volume of 2,285,468.

MPEL Melco Crown Entertainment Limited Recent Headline News

The Single Best Gambling Stock Money Can Buy Right Now
Andrés Cardenal, The Motley Fool - Motley Fool - 50 mins ago
Source: Las Vegas Sands Gambling is well known for being a particularly lucrative industry, after all, the house always wins in the long term. With this in mind, let's look at three major industry players -- Las Vegas Sands , Wynn Resorts , and...
MPEL: 25.18 (+0.41), WYNN: 178.17 (+0.99), LVS: 59.47 (-0.06)

3 Reasons Wynn Resorts' Stock Could Fall
Travis Hoium, The Motley Fool - Motley Fool - Fri Nov 07, 12:30PM CST
Gaming stocks have underperformed the market in 2014, and Wynn Resorts stock has been no different. A slowing gaming market in Macau has made investors skittish about buying into even the industry's best stocks and the sell-off has been...
MPEL: 25.18 (+0.41), WYNN: 178.17 (+0.99), LVS: 59.47 (-0.06)

Melco Crown Lags Q3 Earnings, Revenues, Macau Still Weak - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 12:00PM CST
Melco Crown Entertainment Limited (MPEL) posted third-quarter 2014 results, wherein both earnings and revenues missed the Zacks Consensus Estimate.
MPEL: 25.18 (+0.41), WYNN: 178.17 (+0.99), LVS: 59.47 (-0.06), MGM: 22.20 (+0.26)

3 Reasons Wynn Resorts' Stock Could Rise
Travis Hoium, The Motley Fool - Motley Fool - Fri Nov 07, 8:11AM CST
Wynn Las Vegas. Source: Wynn Resorts. There's a lot of uncertainty in the industry right now, especially for those with exposure to Macau, the world's largest gaming market. Gambling by high rollers has fallen off a cliff in the past six months due...
MPEL: 25.18 (+0.41), WYNN: 178.17 (+0.99), LVS: 59.47 (-0.06)

Downgrade Alert for Melco Crown Entertainment (MPEL)
Comtex SmarTrend(R) - Fri Nov 07, 8:03AM CST
Melco Crown Entertainment (NASDAQ:MPEL) was downgraded from Overweight to Neutral at JP Morgan today. The stock closed yesterday at $24.68 on volume of 5.9 million shares, above average daily volume of 4.2 million. Melco Crown Entertainment has overhead space with shares priced $24.68, or 31.0% below the average consensus analyst price target of $35.79. The stock should find initial resistance at its 50-day moving average (MA) of $26.20 and further resistance at its 200-day MA of $33.44.
MPEL: 25.18 (+0.41)

Melco Crown Entertainment (MPEL) Earnings Report: Q3 2014 Conference Call Transcript
at The Street - Fri Nov 07, 5:35AM CST
The following Melco Crown Entertainment (MPEL) conference call took place on November 6, 2014, 08:30 AM ET. This is a transcript of that earnings call:
MPEL: 25.18 (+0.41)

Melco Crown Entertainment Announces Unaudited Third Quarter 2014 Earnings
GlobeNewswire - Thu Nov 06, 7:11AM CST
Melco Crown Entertainment Limited ("Melco Crown Entertainment" or "the Company" or "we" (SEHK:6883) (Nasdaq:MPEL), a developer, owner and operator of casino gaming and entertainment resort facilities in Asia, today reported its unaudited financial results for the third quarter of 2014.
MPEL: 25.18 (+0.41)

Look for Shares of Melco Crown Entertainment to Potentially Rebound after Yesterday's 4.22% Sell Off
Comtex SmarTrend(R) - Wed Nov 05, 4:41PM CST
Melco Crown Entertainment (NASDAQ:MPEL) traded in a range yesterday that spanned from a low of $24.09 to a high of $24.59. Yesterday, the shares fell 4.2%, which took the trading range below the 3-day low of $24.82 on volume of 7.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
MPEL: 25.18 (+0.41)

Will Melco Crown (MPEL) Miss Q3 Earnings on Macau Woes? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 4:30PM CST
Melco Crown Entertainment Limited (MPEL) is slated to report its third-quarter 2014 results on Nov 6, 2014.
ISLE: 7.40 (+0.04), PNK: 22.51 (-0.34), MPEL: 25.18 (+0.41), DIS: 89.32 (-0.68)

Melco Crown Entertainment (MPEL) Stock Declining Following Weak Macau October Revenue
at The Street - Wed Nov 05, 12:17PM CST
Melco Crown Entertainment (MPEL) shares are falling after the Macau region reported a 23% decline in gaming revenue.
MPEL: 25.18 (+0.41)

ENR, ARQL, ERF, HALL, ERJ, MPEL Expected To Be Down Before Next Earnings Releases
M2 - Wed Nov 05, 5:37AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released in the coming weeks and determining how the stocks have performed Before their last 12 quarterly, 6 quarterly and November earnings reports. Energizer Holdings Inc (NYSE:ENR), ArQule Inc (NASDAQ:ARQL), Enerplus Corp (NYSE:ERF), Hallmark Financial Services Inc (NASDAQ:HALL), Embraer SA (NYSE:ERJ), Melco Crown Entertainment Limited (NASDAQ:MPEL) are all expected to be Down Before their earnings are released. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go Down Before earnings are released Wednesday:
ERF: 14.53 (-0.25), ERJ: 36.33 (-1.23), HALL: 11.03 (-0.67), MPEL: 25.18 (+0.41), ARQL: 1.16 (+0.10), ENR: 125.02 (+1.52)

MGM Resorts International (MGM) Stock Declining Today After Macau Revenue Results
at The Street - Tue Nov 04, 2:24PM CST
MGM Resorts International (MGM) stock is down after revenue results out of Macau showed a 23% year-over-year decline for October.
MPEL: 25.18 (+0.41), LVS: 59.47 (-0.06), MGM: 22.20 (+0.26)

7 Macau Photos Gambling Investors Need to See
Bradley Seth McNew, The Motley Fool - Motley Fool - Mon Nov 03, 7:08PM CST
Macau's gambling market has definitely seen less spectacular results this year than last. The major gambling companies there, including Las Vegas Sands , MGM Resorts International , Wynn Resorts , and Melco Crown , have each felt the sting of...
NKE: 94.89 (+1.11), MPEL: 25.18 (+0.41), WYNN: 178.17 (+0.99), LVS: 59.47 (-0.06), MGM: 22.20 (+0.26)

MGM Resorts Posts Q3 Loss on Weak Gambling Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 11:50AM CDT
MGM Resorts (MGM) posted loss that compared unfavorably with Zacks Consensus Estimate of earnings of 6 cents while revenues marginally beat the consensus mark.
MPEL: 25.18 (+0.41), WYNN: 178.17 (+0.99), LVS: 59.47 (-0.06), MGM: 22.20 (+0.26)

Slumping Sands, Other Macau Casinos Face Overcapacity
at Investor's Business Daily - Fri Oct 31, 9:47AM CDT
Hedge fund manager Jim Chanos warned that he expects overcapacity will squeeze profits for Macau-centric casinos such as Las Vegas Sands (LVS). Sands and other casino stocks shrugged off the reports as casino stocks staged a strong rally early...
MPEL: 25.18 (+0.41), WYNN: 178.17 (+0.99), LVS: 59.47 (-0.06), MGM: 22.20 (+0.26)

'Mad Money' Lightning Round: Go With UPS, Not YRC Worldwide
at The Street - Fri Oct 31, 5:00AM CDT
Cramer is avoiding Armour Residential, says take the loss on Westport Innovations and think long term about Schlumberger.
WPRT: 5.88 (-0.18), DO: 37.23 (-1.51), ETP: 66.12 (+0.11), ARR: 3.98 (unch), MPEL: 25.18 (+0.41), WNC: 10.69 (+0.05), MGM: 22.20 (+0.26), ATK: 108.99 (+0.16), YRCW: 24.50 (+0.53), UPS: 109.05 (+0.72), SLB: 99.10 (+0.37)

Jim Cramer's 'Mad Money' Recap: Here's Why the Bears Were Dead Wrong
at The Street - Thu Oct 30, 7:11PM CDT
The end of quantitative easing was supposed to create a laundry list of problems, Cramer says. It didn't happen.
MMM: 157.28 (+0.73), BIIB: 325.03 (+4.28), HON: 97.16 (+0.39), FB: 75.12 (-0.48), BMY: 58.57 (+0.25), MGM: 22.20 (+0.26), ATK: 108.99 (+0.16), YRCW: 24.50 (+0.53), UPS: 109.05 (+0.72), SLB: 99.10 (+0.37), CELG: 107.70 (+1.25), WPRT: 5.88 (-0.18), SBUX: 77.69 (-0.10), TTWO: 26.15 (-0.01), DO: 37.23 (-1.51), ETP: 66.12 (+0.11), GILD: 107.17 (+0.72), ARR: 3.98 (unch), CMG: 647.86 (-1.17), MPEL: 25.18 (+0.41), WNC: 10.69 (+0.05), CRL: 63.81 (+0.45), AAPL: 108.98 (-0.03), REGN: 383.00 (+5.16)

Is Las Vegas Sands Stock a Buy?
Travis Hoium, The Motley Fool - Motley Fool - Thu Oct 30, 3:15PM CDT
Shares of Las Vegas Sands stock are down 19% year to date and there are brewing questions about whether a recent slip in Macau's gaming market -- where the company gets most of its revenue -- is a short-term slump or a long-term decline. Third...
MPEL: 25.18 (+0.41), LVS: 59.47 (-0.06)

Watch for Melco Crown Entertainment to Potentially Pullback After Gaining 2.39% Yesterday
Comtex SmarTrend(R) - Wed Oct 29, 5:06PM CDT
Melco Crown Entertainment (NASDAQ:MPEL) traded in a range yesterday that spanned from a low of $25.95 to a high of $26.45. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of $25.85 on volume of 3.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MPEL: 25.18 (+0.41)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 190

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 230

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 144

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 242

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 59

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 80

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 299

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 242

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 96

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 104

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading

Top 5 Most Recently Viewed Articles

Michael Burry Steps Back: Scion Asset Management Shuttered

Updated Category News Views 409

Michael Burry Withdraws Scion Asset Management Registration Michael Burry, renowned for his insightful market predictions, has recently decided to de-register his hedge fund, Scion Asset Management, LLC. This decision marks a significant transition in Burry's investment journey. Understanding the De-Registration Process According to the Securities and Exchange...

Continue Reading
Delta Air Lines Takes Legal Action Against CrowdStrike Over Disruption

Updated Category News Views 540

Delta Air Lines Challenges CrowdStrike in Court Delta Air Lines (NYSE: DAL) has taken a bold step by filing a lawsuit against CrowdStrike (NASDAQ: CRWD), arising from significant operational disruptions caused by a software update. This action is taking place in a Georgia state court, specifically the Fulton County Superior Court. Mass Flight Disruptions and Their...

Continue Reading
Innovative LungFit PH Gains Approval for Use in Australia

Updated Category News Views 178

Introduction of LungFit PH in Australia Beyond Air, Inc. (NASDAQ: XAIR) has exciting news for the medical field as it recently received market authorization for its LungFit PH system from the Australian Therapeutic Goods Administration (TGA). This development positions LungFit PH as a Class IIb medical device, designed to provide a controlled application of nitric oxide...

Continue Reading
Integral Molecular Introduces Paratope-PLUS™ for Antibody Claims

Updated Category News Views 169

Integral Molecular Unveils Paratope-PLUS™ for Enhanced Antibody Patenting This innovative technology aligns with new USPTO guidelines for writing robust antibody patent claims and supports advanced antibody engineering for unique intellectual property. Integral Molecular has launched a revolutionary service named Paratope-PLUS™. This new technology aims to improve...

Continue Reading
Nauticus Robotics Growth in Q2: A Positive Outlook Ahead

Updated Category News Views 223

Nauticus Robotics Shows Strong Growth Trajectory in Q2 Nauticus Robotics, Inc. (NASDAQ: KITT), a leading innovator in subsea robotics and software, has demonstrated remarkable momentum in its financial results for the second quarter. The company continues to expand its market presence and innovate its service offerings, reflecting a strong commitment to long-term,...

Continue Reading